As described below, the present invention features compositions and methods for treating brain and/or behavioral health disorders and their associated symptoms.

As described below, the present invention features compositions and methods for treating brain and/or behavioral health disorders and their associated symptoms.

As described below, the present invention features compositions and methods for treating brain and/or behavioral health disorders and their associated symptoms.

There are no medical treatments available for cognitive decline in humans. Prevention through improved lifestyle, especially related to diet, is the one way to reduce the risk. Paradoxically, the modern diet is one that increases dementia risk and worsens cognitive function. Therefore it is critical that new methods be developed based on nutrient therapy.

There are no medical treatments available for cognitive decline in humans. Prevention through improved lifestyle, especially related to diet, is the one way to reduce the risk. Paradoxically, the modern diet is one that increases dementia risk and worsens cognitive function. Therefore it is critical that new methods be developed based on nutrient therapy.

Softgel capsules have a fill composition that administers a 200 to 500 mg dose of magnesium from magnesium oxide and an outer sofgel gelatin shell. The composition includes 55 to 70% w/w of an edible oil, 2 to 8% w/w polysorbate 80, 0.5 to 2% w/w hydrophobic silica, and 0.2 to 4% w/w of a chelating agent for binding to magnesium. The softgel capsules have a dissolution according to USP <711> of greater than NLT 75% (Q).

Softgel capsules have a fill composition that administers a 200 to 500 mg dose of magnesium from magnesium oxide and an outer sofgel gelatin shell. The composition includes 55 to 70% w/w of an edible oil, 2 to 8% w/w polysorbate 80, 0.5 to 2% w/w hydrophobic silica, and 0.2 to 4% w/w of a chelating agent for binding to magnesium. The softgel capsules have a dissolution according to USP <711> of greater than NLT 75% (Q).

A composition comprising nanoparticles, a method for the preparation of a composition comprising nanoparticles and uses of the composition for dental treatment are provided. Each nanoparticle is made of polymeric material and includes an antimicrobial agent encapsulated therein. The polymeric material can include Poly(lactic-co-glycolic acid) (PLGA), or other polymers such as Polylactic (PLA), Polyglycolic (PGA), or Polycaprolactone (PCL). The active molecule is calcium hydroxide in the range of 0.1 to 5 mg/ml. The composition has a pH in the range of 8-13.

This invention concerns a formulation of a hydrated mixed metal hydroxide and a nontoxic, non-anionic thickener, to form a salve or lotion which does cause synereses of the formulation. This formulation, when applied to a person or animal, forms a film that acts as an astringent, has antimicrobial palliative properties for many negative pathogens, burns, rashes and other skin maladies.

This invention concerns a formulation of a hydrated mixed metal hydroxide and a nontoxic, non-anionic thickener, to form a salve or lotion which does cause synereses of the formulation. This formulation, when applied to a person or animal, forms a film that acts as an astringent, has antimicrobial palliative properties for many negative pathogens, burns, rashes and other skin maladies.